68083-412Level 3
Cangrelor (Cangrelor)
**Product type:** Human Prescription Drug
**Active ingredient:** CANGRELOR
**Strength:** 50 mg/1
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Gland Pharma Limited
**Marketing category:** ANDA (ANDA213551)
**Pharmacologic class:** Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/68083-412Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.